These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stereospecific recognition of inositol 1,4,5-trisphosphate analogs by the phosphatase, kinase, and binding proteins. Hirata M; Yanaga F; Koga T; Ogasawara T; Watanabe Y; Ozaki S J Biol Chem; 1990 May; 265(15):8404-7. PubMed ID: 2160455 [TBL] [Abstract][Full Text] [Related]
3. Synthetic inositol trisphosphate analogs and their effects on phosphatase, kinase, and the release of Ca2+. Hirata M; Watanabe Y; Ishimatsu T; Ikebe T; Kimura Y; Yamaguchi K; Ozaki S; Koga T J Biol Chem; 1989 Dec; 264(34):20303-8. PubMed ID: 2555352 [TBL] [Abstract][Full Text] [Related]
4. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes. Hirata M; Watanabe Y; Yoshida M; Koga T; Ozaki S J Biol Chem; 1993 Sep; 268(26):19260-6. PubMed ID: 8396130 [TBL] [Abstract][Full Text] [Related]
5. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate. Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676 [TBL] [Abstract][Full Text] [Related]
6. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities. Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885 [TBL] [Abstract][Full Text] [Related]
7. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase. Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823 [TBL] [Abstract][Full Text] [Related]
8. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase. Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biology of inositol polyphosphate analogues. Potter BV; Nahorski SR Biochem Soc Trans; 1992 May; 20(2):434-42. PubMed ID: 1327920 [No Abstract] [Full Text] [Related]
10. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor. Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex. Guillemette G; Lamontagne S; Boulay G; Mouillac B Mol Pharmacol; 1989 Mar; 35(3):339-44. PubMed ID: 2538711 [TBL] [Abstract][Full Text] [Related]
12. Formation and actions of calcium-mobilizing messenger, inositol 1,4,5-trisphosphate. Putney JW Am J Physiol; 1987 Feb; 252(2 Pt 1):G149-57. PubMed ID: 3030126 [TBL] [Abstract][Full Text] [Related]
13. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase. Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949 [TBL] [Abstract][Full Text] [Related]
14. Characterization of inositol 1,4,5-trisphosphate receptors and calcium mobilization in a hepatic plasma membrane fraction. Guillemette G; Balla T; Baukal AJ; Catt KJ J Biol Chem; 1988 Apr; 263(10):4541-8. PubMed ID: 2832398 [TBL] [Abstract][Full Text] [Related]
15. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor. Takahashi M; Tanzawa K; Takahashi S J Biol Chem; 1994 Jan; 269(1):369-72. PubMed ID: 8276820 [TBL] [Abstract][Full Text] [Related]
16. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes. Yoshimura K; Watanabe Y; Erneux C; Hirata M Cell Signal; 1999 Feb; 11(2):117-25. PubMed ID: 10048789 [TBL] [Abstract][Full Text] [Related]
17. The metabolism of tris- and tetraphosphates of inositol by 5-phosphomonoesterase and 3-kinase enzymes. Connolly TM; Bansal VS; Bross TE; Irvine RF; Majerus PW J Biol Chem; 1987 Feb; 262(5):2146-9. PubMed ID: 3029066 [TBL] [Abstract][Full Text] [Related]
18. Inositol 1:2-cyclic,4,5-trisphosphate is only a weak agonist at inositol 1,4,5-trisphosphate receptors. Willcocks AL; Strupish J; Irvine RF; Nahorski SR Biochem J; 1989 Jan; 257(1):297-300. PubMed ID: 2537626 [TBL] [Abstract][Full Text] [Related]
19. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase. Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165 [TBL] [Abstract][Full Text] [Related]
20. Formation and metabolism of [3H]inositol phosphates in AR42J pancreatoma cells. Substance P-induced Ca2+ mobilization in the apparent absence of inositol 1,4,5-trisphosphate 3-kinase activity. Horstman DA; Takemura H; Putney JW J Biol Chem; 1988 Oct; 263(30):15297-303. PubMed ID: 2459122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]